Malignant tumours of the minor salivary glands: a survival analysis of 17 years from a tertiary referral cancer centre.
BACKGROUND: Malignant tumours of the minor salivary glands are rare and constitute less than 0.5% of all malignant neoplasms. AIM: This study was carried out to evaluate the clinical presentation, site distribution, treatment, survival and predictors of survival in malignant minor salivary gland tumours. SETTING: A tertiary care, superspeciality referral hospital. DESIGN: Retrospective analysis. PATIENTS AND METHOD: Forty-two cases of minor salivary gland tumours treated over a period of 17 years were reviewed for clinical presentation, histopathology, stage distribution, treatment and treatment outcome. STATISTICAL ANALYSIS: Survival by Kaplan Meier Method and the outcomes were compared using log-rank test. RESULTS: The mean age of the patients was 46.9 years with a male to female ratio of 1.4:1. Majority of the patients presented with a painless progressive swelling, with 13 (31%) of them in T2 stage. About one-third of the patients had palpable lymph nodes at presentation, while none had distant metastasis. Palate was the commonest site and mucoepidermoid carcinoma was the commonest hispathological type. About 1/3 of the patients were treated with primary surgery and were followed up by adjuvant radiotherapy. Seven patients underwent palliative treatment alone. Over a mean follow-up of 30 months, 5 patients failed. The disease free survival was 72% at 5-year, none of the factors studied were found to significantly influence survival. CONCLUSIONS: Results of the present study suggest that minor salivary gland tumours should be treated with primary surgery irrespective of site and histological type to achieve best loco-regional control and survival..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2003 |
|---|---|
| Erschienen: |
2003 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:49 |
|---|---|
| Enthalten in: |
Journal of Postgraduate Medicine - 49(2003), 1, Seite 25-8 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Pandey M [VerfasserIn] |
|---|
| Links: |
doaj.org [kostenfrei] |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
DOAJ008575819 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ008575819 | ||
| 003 | DE-627 | ||
| 005 | 20230310012152.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230225s2003 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)DOAJ008575819 | ||
| 035 | |a (DE-599)DOAJb0ef81e634ac4f9ea7bb327d8d775fb1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a Pandey M |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Malignant tumours of the minor salivary glands: a survival analysis of 17 years from a tertiary referral cancer centre. |
| 264 | 1 | |c 2003 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a BACKGROUND: Malignant tumours of the minor salivary glands are rare and constitute less than 0.5% of all malignant neoplasms. AIM: This study was carried out to evaluate the clinical presentation, site distribution, treatment, survival and predictors of survival in malignant minor salivary gland tumours. SETTING: A tertiary care, superspeciality referral hospital. DESIGN: Retrospective analysis. PATIENTS AND METHOD: Forty-two cases of minor salivary gland tumours treated over a period of 17 years were reviewed for clinical presentation, histopathology, stage distribution, treatment and treatment outcome. STATISTICAL ANALYSIS: Survival by Kaplan Meier Method and the outcomes were compared using log-rank test. RESULTS: The mean age of the patients was 46.9 years with a male to female ratio of 1.4:1. Majority of the patients presented with a painless progressive swelling, with 13 (31%) of them in T2 stage. About one-third of the patients had palpable lymph nodes at presentation, while none had distant metastasis. Palate was the commonest site and mucoepidermoid carcinoma was the commonest hispathological type. About 1/3 of the patients were treated with primary surgery and were followed up by adjuvant radiotherapy. Seven patients underwent palliative treatment alone. Over a mean follow-up of 30 months, 5 patients failed. The disease free survival was 72% at 5-year, none of the factors studied were found to significantly influence survival. CONCLUSIONS: Results of the present study suggest that minor salivary gland tumours should be treated with primary surgery irrespective of site and histological type to achieve best loco-regional control and survival. | ||
| 650 | 4 | |a Adolescent | |
| 650 | 4 | |a Adult | |
| 650 | 4 | |a Aged | |
| 650 | 4 | |a Carcinoma | |
| 650 | 4 | |a diagnosis | |
| 650 | 4 | |a pathology | |
| 650 | 4 | |a therapy | |
| 650 | 4 | |a Disease-Free Survival | |
| 650 | 4 | |a Female | |
| 650 | 4 | |a Human | |
| 650 | 4 | |a Male | |
| 650 | 4 | |a Middle Age | |
| 650 | 4 | |a Neoplasm Staging | |
| 650 | 4 | |a Palate | |
| 650 | 4 | |a Retrospective Studies | |
| 650 | 4 | |a Salivary Gland Neoplasms | |
| 650 | 4 | |a Survival Analysis | |
| 650 | 4 | |a Treatment Outcome | |
| 653 | 0 | |a Medicine | |
| 653 | 0 | |a R | |
| 700 | 0 | |a Thomas S |e verfasserin |4 aut | |
| 700 | 0 | |a Mathew A |e verfasserin |4 aut | |
| 700 | 0 | |a Nair M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Journal of Postgraduate Medicine |d Wolters Kluwer Medknow Publications, 2003 |g 49(2003), 1, Seite 25-8 |w (DE-627)DOAJ00006470X |x 09722823 |7 nnns |
| 773 | 1 | 8 | |g volume:49 |g year:2003 |g number:1 |g pages:25-8 |
| 856 | 4 | 0 | |u https://doaj.org/article/b0ef81e634ac4f9ea7bb327d8d775fb1 |z kostenfrei |
| 856 | 4 | 0 | |u http://www.jpgmonline.com/article.asp?issn=0022-3859;year=2003;volume=49;issue=1;spage=25;epage=8;aulast=Pandey |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/0022-3859 |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/0972-2823 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 49 |j 2003 |e 1 |h 25-8 | ||